These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7205636)

  • 1. Evaluation of phencyclidine analogs on the basis of their discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1981 Mar; 216(3):543-51. PubMed ID: 7205636
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of N-substituted analogs and metabolites of phencyclidine on avoidance behavior in the rat.
    Shannon HE; DeGregorio CM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):55-62. PubMed ID: 7241389
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: pharmacological and behavioral characterization of intermediate levels of drug lever selection.
    Koek W; Colpaert FC; Vignon J
    J Pharmacol Exp Ther; 1993 Feb; 264(2):746-56. PubMed ID: 8437123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of PCP mimetics.
    Browne RG
    NIDA Res Monogr; 1986; 64():134-47. PubMed ID: 3086730
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital.
    Overton DA
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):180-9. PubMed ID: 1164086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of brightness discrimination in a shock avoidance task by phencyclidine and its antagonism in rats.
    Tang AH; Franklin SR
    J Pharmacol Exp Ther; 1983 Jun; 225(3):503-8. PubMed ID: 6864515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of phencyclidine derivatives in rats.
    Cone EJ; McQuinn RL; Shannon HE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):147-53. PubMed ID: 6694098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of phencyclidine, etoxadrol and dexoxadrol in the pigeon.
    Leander JD
    Subst Alcohol Actions Misuse; 1982; 3(4):197-203. PubMed ID: 6132451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites.
    Middaugh LD; Favara JP; Boggan WO; Stringer AJ
    Psychopharmacology (Berl); 1988; 96(3):381-4. PubMed ID: 3146772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys.
    Solomon RE; Herling S; Domino EF; Woods JH
    Neuropharmacology; 1982 Dec; 21(12):1329-36. PubMed ID: 7155312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).
    Vivian JA; Waters CA; Szeliga KT; Jordan K; Grant KA
    Psychopharmacology (Berl); 2002 Jul; 162(3):273-81. PubMed ID: 12122485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists.
    Grant KA; Colombo G
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1241-7. PubMed ID: 8450461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of dextromethorphan in rats.
    Gavend M; Mallaret M; Dematteis M; Baragatti G
    Biomed Pharmacother; 1995; 49(10):456-64. PubMed ID: 8746072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle.
    Prus AJ; Philibin SD; Pehrson AL; Porter JH
    Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, phencyclidine-like pharmacology, and antiischemic potential of meta-substituted 1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridines.
    Thurkauf A; de Costa B; Mattson MV; France CP; Price MT; Olney JW; Woods JH; Jacobson AE; Rice KC
    J Med Chem; 1990 Aug; 33(8):2211-5. PubMed ID: 2374147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discriminative stimulus properties of drugs; development and application].
    Yang XM
    Sheng Li Ke Xue Jin Zhan; 1988 Jan; 19(1):47-51. PubMed ID: 3293202
    [No Abstract]   [Full Text] [Related]  

  • 18. Discriminative stimulus properties of (+)-oxaprotiline in rats.
    Filip M; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol; 1993; 45(2):151-6. PubMed ID: 8401767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological properties of sidnocarb analogs].
    Al'tshuler RA; Parshin VA
    Farmakol Toksikol; 1980; 43(2):153-8. PubMed ID: 7002590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphono-heptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonist.
    Bobelis DJ; Balster RL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):845-53. PubMed ID: 8437128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.